VC (corporate holding structure)
Luxembourg & Hong Kong
VC advisor team
Various experienced MedTech and Mobility executives with decades of experience across Europe, the US and Asia
Cross-border VC (Europe and Asia)
Seed, Series A
Average ticket size
EUR 2-4 million, with flexibility
Europe, Israel and Asia
EU impact classification
Article 8 - Promoting ESG
Verticals and technologies
Medtech and Mobility
Ascend Capital Partners
Investing in early-stage Medtech and Mobility companies in Europe and Asia
VC investing in early-stage Medtech and Mobility companies in Europe and Asia, providing hands-on support to expand into Asian, Europa and US.
Grundium (PE buy-out, May-22), Aiforia (IPO, Dec-21), IEE (Trade sale, Jan-13), NVC Lighting (HK IPO), TCT Medical (Trade sale), Acorn International (Nasdaq IPO), Bioregen (PE buy-out), China Autoparts (PE buy-out)
- Launch year:
- Size (AUM):
- Investor involvement:
- Fund management location:
Our vision is for early-stage tech entrepreneurs to realise their full potential by supporting them to capture significant market opportunities in Asia, a geography which they may admire but not have much knowledge, experience or connections to address and, crucially, unlock hidden value in their businesses. We provide close support for our portfolio companies through our active investment approach, bringing financial and industry expertise to bear, as well as connections which blossom into commercial opportunities that accelerate growth. We closely guide entrepreneurs into the market, looking to deepen our strategic support by offering localisation opportunities in Asia, such as setting up local joint ventures and operations. We are a financial investor with a strategic mindset.
Our current portfolio is spread across Europe and Asia, with a strong track record of implementing our successful thesis through them.
All of our partners have substantial experience working in and/or cultural links with Asia, as well as Europe.
- Lead investments:
Yes (e.g. Canatu, TactoTek, Grundium, Aiforia)
- Syndicate investments:
- Follow investments:
EUR 60-80 million
Investing in European high-tech early-stage medtech and mobility tech firms, supporting them to grow in Asia/US, as well as Asian companies and growth in Europe/US